Webinar: From Mutation to Treatment: Understanding the Impact of IDH Inhibitors
Virtual Event Virtual EventJoin this webinar to learn about the role of IDH inhibitors in brain tumor care and explore the latest advancements in IDH-targeted therapies, including the newly FDA-approved treatment, vorasidenib. In this Webinar, you will: Understand what IDH inhibitors are and how they are diagnosed Learn about how IDH inhibitors influence treatment decisions Recognize the role […]
